Project Status

IntegraGen has developed and marketed a risk-assessment tool with a 4-gene test allowing clinical practitioners to identify individuals in autistic families with a high risk of developing autism.

IntegraGen is currently working on the identification, replication and clinical validation of more genes that will allow clinical practitioners and parents to identify not only autistic children (broad spectrum) in families but also children who may present only early symptoms in childhood without any previous history of the disease in the family.

Clinical trials are already in progress.

Strategic Partnerships

IntegraGen seeks partnerships with private and public, clinical, industrial and academic institutions to bring additional Autism products into the development pipeline and eventually in the hands of clinicians and patients. IntegraGen has and will continue to in-license intellectual property from world-class researchers to improve the usefulness and scope of our offers. Partnership can take various forms such as access to DNA cohorts, Scientific co-operations, interships, grants and financial contributions